https://icosagen.eeKoduleht - IcosagenMuudame ideed reaalsuseks Icosagen on pühendunud Eesti biotehnoloogiaettevõte, mis tegeleb terapeutiliste antikehade arendamise ja diagnostiliste rekombinantsete valkude tootmisega imetajate rakkudes nii teadusuuringute kui ka in vitro diagnostika tarbeks. Loe lisaks Meist Teenused Klientide tagasiside “Fast responses, great flexibility, transparency, collaborative spirit, high quality” Ridgeline Kliki siia”Fast reply, quality of reports, good product profile” Pharis Biofarmaceuticals […]
Name
ICO Park OÜ
Registry code
12401945
VAT number
EE101603034
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
08.01.2013 (11)
Financial year
01.01-31.12
Capital
2 502.00 €
Activity
68201 - Rental and operating of own or leased real estate
817 685 €
115 905 €
14%
3 012 €
(estimate is approximate)
3 255 922 €
2
Submitted
No tax arrears
4%
2%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Icosagen AS 10565884 | 100% - 2 502.00 EUR | - | - | Founder |
| Mart Ustav 16.07.1949 (75) | - | Board member | Indirect ownership |
| 2019 11.06.2020 | 2020 30.04.2021 | 2021 03.06.2022 | 2022 31.03.2023 | 2023 10.04.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 403 457 € | 388 278 € | 447 276 € | 618 692 € | 817 685 € |
| Net profit (loss) for the period | 141 201 € | 63 717 € | 175 330 € | 118 655 € | 115 905 € |
| Profit Margin | 35% | 16% | 39% | 19% | 14% |
| Current Assets | 60 786 € | 36 060 € | 73 372 € | 507 209 € | 197 844 € |
| Fixed Assets | 1 950 780 € | 2 048 017 € | 2 054 931 € | 4 114 488 € | 6 798 329 € |
| Total Assets | 2 011 566 € | 2 084 077 € | 2 128 303 € | 4 621 697 € | 6 996 173 € |
| Current Liabilities | 232 334 € | 1 113 458 € | 346 584 € | 771 461 € | 475 467 € |
| Non Current Liabilities | 1 146 918 € | 274 588 € | 910 357 € | 710 219 € | 3 264 784 € |
| Total Liabilities | 1 379 252 € | 1 388 046 € | 1 256 941 € | 1 481 680 € | 3 740 251 € |
| Share Capital | - | - | - | - | - |
| Equity | 632 314 € | 696 031 € | 871 362 € | 3 140 017 € | 3 255 922 € |
| Employees | 2 | 2 | 2 | 2 | 2 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 389 236.45 € | 64 078.31 € | 13 579.91 € | 3 |
| 2023 Q4 | 267 079.33 € | 24 149.03 € | 8 793.68 € | 3 |
| 2023 Q3 | 255 116.63 € | - | 8 868.2 € | 3 |
| 2023 Q2 | 181 720.22 € | - | 8 711.69 € | 3 |
| 2023 Q1 | 204 094.29 € | - | 10 870.8 € | 3 |
| 2022 Q4 | 236 005.27 € | 8 553.31 € | 8 055.31 € | 3 |
| 2022 Q3 | 151 401.12 € | 8 479.91 € | 8 599.24 € | 3 |
| 2022 Q2 | 168 511.52 € | 9 970.74 € | 8 590.81 € | 3 |
| 2022 Q1 | 160 018.5 € | 15 590.72 € | 7 774.66 € | 3 |
| 2021 Q4 | 146 681.13 € | 22 947.63 € | 6 914.65 € | 3 |
| 2021 Q3 | 105 870.3 € | 17 166.14 € | 6 313.93 € | 3 |
| 2021 Q2 | 125 191.76 € | 20 963.99 € | 6 021.36 € | 3 |
| 2021 Q1 | 118 510.44 € | 23 445.66 € | 7 616.75 € | 3 |
| 2020 Q4 | 101 005.93 € | 10 486.38 € | 6 031.65 € | 3 |
| 2020 Q3 | 80 040.41 € | 5 819.43 € | 6 040.77 € | 3 |
| 2020 Q2 | 102 922.22 € | 16 903.7 € | 5 958.82 € | 3 |
| 2020 Q1 | 128 861.1 € | 22 847.13 € | 7 027.01 € | 3 |
